Trial site
Centro de Investigaciones Médicas Tucuman
- 12running trials
- 7closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Obesity8 trials
- Type 2 diabetes4 trials
- Ulcerative colitis3 trials
- Chronic kidney disease2 trials
- Dermatomyositis and polymyositis (myositis)2 trials
- Stroke2 trials
- Alopecia areata1 trial
- Coronary artery disease1 trial
- Heart failure1 trial
- Lupus (SLE)1 trial
- Osteoarthritis1 trial
- Peripheral artery disease1 trial
- and 3 more
- Phase
- Phase 318 trials
- Phase 21 trial
- Status
- Completed6 trials
- Active, not recruiting5 trials
- Recruiting5 trials
- Not yet recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company16 trials
- Pfizer2 trials
- Bristol-Myers Squibb1 trial
Running trials
Not yet recruiting
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity3 recruiting
- Dermatomyositis and polymyositis (myositis)2 recruiting
- Chronic kidney disease1 recruiting
- Osteoarthritis1 recruiting
- Psoriasis1 recruiting
- Stroke1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Terminated
Completed
Completed
A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026